Abstract
The human body is highly organized in time and most functions display significant daily [circadian] and seasonal rhythms. Gene expression in the brain as well in the peripheral tissues has been convincingly demonstrated to be circadian phase dependent for many genes. In addition, seasonal gene expression – with inverse rhythms in the Northern and Southern Hemisphere – has been evidenced as well. Taking into account these rhythmic changes in the body, it is conceivable that also the pharmacokinetics and/or the pharmacodynamics can be rhythmic in experimental animals as well in humans. In this review chronopharmacological findings are compiled demonstrating to what an extent rhythmic changes in the composition of the body in health and disease can contribute to variations in time-dependent drug treatments. The results of clinical chronopharmacological studies in hypertension, asthma, and ulcer disease and treatment of antihyperlipidemia are reviewed.
References and Further Reading
Albrecht U (2012) Timing to perfection: the biology of central and peripheral circadian clocks. Neuron 74(2):246–260. https://doi.org/10.1016/j.neuron.2012.04.006
Allwinn R et al (2009) Arzneiverordnungen. In: Arzneimittelkommission, der, deutschen, Ärzteschaft (eds). 22 edn. Medizinische Medien Informations GmbH, Neu Isenburg
Aschoff J (1947) Einige allgemeine Gesetzmäßigkeiten physikalischer Temperaturregulation. Pflügers Arch 249:125–136
Bruguerolle B, Bouvenot G, Bartolin R, Manolis J (1988) Chronopharmacocinetique de la digoxine chez le sujet de plus de soixante-dix ans. Therapie 43:251–253
Chen CY et al (2016) Effects of aging on circadian patterns of gene expression in the human prefrontal cortex. Proc Natl Acad Sci U S A 113(1):206–211. https://doi.org/10.1073/pnas.1508249112
Cilla DD, Gibson DM, Whitfield LR, Sedman AJ (1996) Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening. J Clin Pharmacol 36:604–609
Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA (2012) The human circadian metabolome. Proc Natl Acad Sci U S A 109(7):2625–2629. https://doi.org/10.1073/pnas.1114410109
Dopico XC et al (2015) Widespread seasonal gene expression reveals annual differences in human immunity and physiology. Nat Commun 6:7000. https://doi.org/10.1038/ncomms8000
Fukuda M et al (2008) Angiotensin II type 1 receptor blocker, olmesartan, restores nocturnal blood pressure decline by enhancing daytime natriuresis. J Hypertens 26(3):583–588
Goo RH, Moore JG, Greenberg E, Alazraki NP (1987) Circadian variation in gastric emptying of meals in humans. Gastroenterology 93:515–518
Hermida RC et al (2003) Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension 42(3):283–290
Hermida RC, Ayala DE, Fernandez JR, Calvo C (2007a) Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension 50(4):715–722
Hermida RC, Ayala DE, Smolensky MH, Portaluppi F (2007b) Chronotherapy in hypertensive patients: administration-time dependent effects of treatment on blood pressure regulation. Expert Rev Cardiovasc Ther 5(3):463–475
Hla KK, Latham AN, Henry JA (1992) Influence of time of administration on verapamil pharmacokinetics. Clin Pharmacol Ther 51(4):366–370
Illingworth DR (1986) Comparative efficacy of once versus twice daily mevinolin in the therapy of familial hypercholesterolemia. Clin Pharmacol Ther 40:338–343
Jespersen CM, Frederiksen M, Hansen JF, Klitgaard NA, Sorum C (1989) Circadian variation in the pharmacokinetics of verapamil. Eur J Clin Pharmacol 37(6):613–615
Koopmans R, Oosterhuis B, Karemaker JM, Wemer J, van Boxtel CJ (1993) The effect of oxprenolol dosage time on its pharmacokinetics and haemodynamic effects during exercise in man. Eur J Clin Pharmacol 44:171–176.
Konopka RJ, Benzer S (1971) Clock mutants of Drosophila melanogaster. Proc Natl Acad Sci U S A 68(9):2112–2116
Langner B, Lemmer B (1988) Circadian changes in the pharmacokinetics and cardiovascular effects of oral propranolol in healthy subjects. Eur J Clin Pharmacol 33:619–624
Lemmer B, Behne S, Becker HJ (1989) Chronopharmacology of oral nifedipine in healthy subjects. Eur J Clin Pharmacol 36 Suppl:A 177
Lemmer B (1991a) Circadian rhythms and drug delivery. J Control Release 16:63–74
Lemmer B (1991b) Implications of chronopharmacokinetics for drug delivery: antiasthmatics, H2-blockers and cardiovascular active drugs. Adv Drug Deliv Rev 6:83–100
Lemmer B (2005) Chronopharmacology and controlled drug release. Expert Opin Drug Deliv 2(4):667–681
Lemmer B (2006) The importance of circadian rhythms on drug response in hypertension and coronary heart disease – from mice and man. Pharmacol Ther 111(3):629–651
Lemmer B (2007a) Chronobiology and chronopharmacology of hypertension. In: White WB (ed) Clinical hypertension and vascular disease: blood pressure monitoring in cardiovascular medicine and therapeutics, 2nd edn. Humana Press, Totowa, pp 413–435
Lemmer B (2007b) Chronobiology and chronopharmacology of hypertension: importance of timing of dosing. In: White WB (ed) Blood pressure monitoring in cardiovascular medicine and therapeutics, 2nd edn. Humana Press, Totowa, pp 410–435
Lemmer B (2007c) Hypertension: do we need to consider the biological clock in drug dosing? Expert Rev Cardiovasc Ther 5(3):375–379
Lemmer B (2009) Discoveries of rhythms in human biological functions: a historical review. Chronobiol Int 26(6):1019–1068
Lemmer B (2012a) Chronopharmakologie, 4th edn. Wiss. Verlagsges, Stuttgart
Lemmer B (2012b) Masking effect of modern technology on annual rhythms: variation in births and deaths in a single family history over five centuries. Chronobiol Int 26:1019–1068
Lemmer B (2014) Seasonal variation in nativity and mortality and in socioeconomic conditions in a single family residing at different latitudes: Germany versus South Africa. ChronoPhysiol Ther 4:59–66
Lemmer B (2017) Signal transduction and chronopharmacology of regulation of circadian cardiovascular rhythms in animal models of human hypertension. Heart Fail Clin. https://doi.org/10.1016/j.hfc.2017.05.009
Lemmer B, Bruguerolle B (1994) Chronopharmacokinetics. Are they clinically relevant? Clin Pharmacokinet 26(6):419–427
Lemmer B, Nold G (1991) Circadian changes in estimated hepatic blood flow in healthy subjects. Br J Clin Pharmacol 32:627–629
Lemmer B, Portaluppi F (1997) Chronopharmacology of cardiovascular diseases. In: Redfern PH, Lemmer B (eds) Physiology and pharmacology of biological rhythms, Handbook of experimental pharmacology, vol 125. Springer, Berlin, pp 251–297
Lemmer B, Nold G, Behne S, Becker HJ, Liefhold J, Kaiser R (1990) Chronopharmacology of oral nifedipine in healthy subjects and in hypertensive patients. Eur J Pharmacol 183:521
Lemmer B, Nold G, Behne S, Kaiser R (1991a) Chronopharmacokinetics and cardiovascular effects of nifedipine. Chronobiol Int 8(6):485–494
Lemmer B, Scheidel B, Blume H, Becker HJ (1991b) Clinical chronopharmacology of oral sustained-release isosorbide-5-mononitrate in healthy subjects. Eur J Clin Pharmacol 40:71–75
Lemmer B, Middeke M, Schaaf B, Eckes L (2008) Prescribing practices and morning blood pressure control: results of a large-scale, primary-care study conducted in Germany. J Hum Hypertens 22(4):295–297
Manfredini R et al (2012) Twenty-four-hour patterns in occurrence and pathophysiology of acute cardiovascular events and ischemic heart disease. Chronobiol Int. https://doi.org/10.3109/07420528.2012.715843
Manfredini R, Salmi R, Cappadona R, Signani F, Basili S, Katsiki N (2017) Sex and circadian periodicity of cardiovascular diseases. Heart Fail Clin. https://doi.org/10.1016/j.hfc.2017.05.008
Moore JG (1989) Circadian rhythmicity in gastric emptying, acid secretion, and mucosal damage by drugs: implications for drug therapy. In: Lemmer B (ed) Chronopharmacology – biochemical and cellular interactions, Chronopharmacology – cellular and biochemical interactions. Marcel Dekker, New York, pp 631–654
Nold G, Lemmer B (1998) Pharmacokinetics of sustained-release molsidomine after morning versus evening application in healthy subjects. Naunyn Schmiedebergs Arch Pharmacol 357:R173.
Nold G, Strobel G, Lemmer B (1998) Morning versus evening amlodipine: effect on circadian blood pressure profile in essential hypertensive patients. Blood Press Monit 3:17–25.
Pechere-Bertschi A et al (1998) Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients. J Hypertens 16:385–393
Saito Y, Yoshida S, Nakaya N, Hata Y, Goto Y (1991) Comparison between morning and evening doses of simvastatin in hyperlipidemic subjects a double-blind comparative study. Arterioscler Thromb 11(4):816–826
Sanders SW, Moore JG, Buci KN, Bishop AL (1988) Circadian variation in the pharmacodynamic effects of intravenous ranitidine. Annu Rev Chronopharmacol 5:335–338
Semenowicz-Siuda K, Markiewicz A, Korczynska-Wardecka J (1984) Circadian bioavailability and some effects of propranolol in healthy subjects and in liver cirrhosis. Int J Clin Pharmacol Ther Toxicol 22:653–658.
Scheidel B, Lemmer B (1991) Chronopharmacology of oral nitrates in healthy subjects. Chronobiol Int 8:409–419
Smolensky MH, Hermida RC, Portaluppi F (2007a) Comparison of the efficacy of morning versus evening administration of olmesartan in uncomplicated essential hypertension. Chronobiol Int 24(1):171–181
Smolensky MH, Lemmer B, Reinberg AE (2007b) Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. Adv Drug Deliv Rev 59(9–10):852–882
Triscari J, Rossi L, Pan HY (1995) Chronokinetics of pravastatin administered in the PM compared with AM dosing. Am J Ther 2(4):265–268
Uzu T, Kimura G (1999) Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation 100(15):1635–1638
Wallace A, Chinn D, Rubin G (2003) Taking simvastatin in the morning compared with in the evening: randomised controlled trial. BMJ 327(7418):788
Witte K et al (1993) Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration. Clin Pharmacol Ther 54:177–186
Disclosure
The author has no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this entry
Cite this entry
Lemmer, B. (2017). Chronopharmacology in Drug Development. In: Hock, F., Gralinski, M. (eds) Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Springer, Cham. https://doi.org/10.1007/978-3-319-56637-5_40-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-56637-5_40-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-56637-5
Online ISBN: 978-3-319-56637-5
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences